Rocket Pharmaceuticals, Inc.
RCKT
$2.86
-$0.075-2.56%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -61.33M | -60.33M | -66.72M | -69.65M | -62.05M |
| Total Depreciation and Amortization | 2.99M | 2.36M | 2.39M | 2.37M | 2.25M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.26M | 11.74M | 9.40M | 9.09M | 8.61M |
| Change in Net Operating Assets | -5.70M | -717.00K | 2.83M | 4.36M | -5.67M |
| Cash from Operations | -55.79M | -46.94M | -52.10M | -53.82M | -56.86M |
| Capital Expenditure | -364.00K | -309.00K | -1.59M | -1.93M | -2.04M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -57.67M | -37.56M | 80.51M | 57.55M | 37.07M |
| Cash from Investing | -58.04M | -37.87M | 78.92M | 55.62M | 35.03M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 182.85M | 176.00K | 1.53M | 1.18M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 182.85M | 176.00K | 1.53M | 1.18M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -113.83M | 98.04M | 26.99M | 3.33M | -20.64M |